Update for PP405 - phase 2b underway
    Research/Science 2/8/2025

    At a glance
    In this research update post, the primary subjects mentioned are
    💧 PP405 (topical) 0.05%
    the tone is 😀 positive with some growth results.

    Other terms

    PP405 is advancing to Phase 2b trials, showing promise from Phase 2a. It may be available in 3-6 years, with trials using a topical gel.
    View this post in the Community →

    Similar Community Posts Join

    5 / 54 results

      community The Cure isn't 5 years away; it's already here.

      in Research/Science  1007 upvotes 2 months ago
      PP405 is a new topical treatment for hair loss, showing promise in trials but still requires finasteride for maintenance. There is skepticism about its effectiveness and safety, with concerns about needing finasteride to maintain results.

      community What to look Forward to in 2025

      in Research/Science  17 upvotes 1 month ago
      Hair loss treatments are advancing, with Coegin Pharma's FOL005 expected this year and Breezula potentially later. Pyrilutamide is available but not very effective, while Kintor's products face skepticism; traditional treatments like finasteride and minoxidil remain dominant.

      community How far are we from a treatment better than finasteride?

      in Treatment  129 upvotes 2 weeks ago
      Dutasteride is more effective than finasteride for hair loss as it blocks more of the enzyme causing hair loss. New treatments like stem cell therapies and alternatives to minoxidil are being explored, but major advancements are still years away.

      community PP405 - hair stem cell stimulation

      in Research/Science  51 upvotes 1 year ago
      PP405, a topical LDH inhibitor, has shown to stimulate hair follicle stem cell proliferation in humans with moderate hair loss. They are advancing to more detailed trials this year.

    Related Research

    6 / 17 results